Korean Market
EXCH
Hanmi Science
★
Hanmi Pharm Signs 52.7 Billion KRW, 10-Year Supply Contract with Organon for 3 CV/Respiratory Drugs
 7h ago
PERI
Hanmi Science
★★★
Hanmi Science Reports 24% Operating Profit Growth in Q1 2026 and Strengthens Shareholder Returns
 05/15/2026, 04:46 PM
EXCH
Hanmi Science
★★★
Hanmi Science Q1 2026: Net profit +73% YoY, Operating profit +24% YoY
 05/03/2026, 07:00 AM